Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Teva, Amgen end dispute over generic Cinacalcet HCl tablets

January 3, 2019 2:33 AM
74 0

(Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA) said on Thursday it will pay an undisclosed amount to settle an ongoing dispute with Amgen Inc (AMGN.O) over its generic Cinacalcet HCl product.

The Israel-based drugmaker has also agreed to stop selling the generic product until its license date in mid-year 2021, or earlier under certain circumstances reut.rs/2BUnEad.

Read more

Share in social networks:

Comments - 0